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A B S T R A C T
Hensen's node is the “organizer” of the avian and mammalian early embryo. It has many functions, including
neural induction and patterning of the ectoderm and mesoderm. Some of the signals responsible for these
activities are known but these do not explain the full complexity of organizer activity. Here we undertake a
functional screen to discover new secreted factors expressed by the node at this time of development. Using a
Signal Sequence Trap in yeast, we identify several candidates. Here we focus on Calreticulin. We show that in
addition to its known functions in intracellular Calcium regulation and protein folding, Calreticulin is secreted,
it can bind to BMP4 and act as a BMP antagonist in vivo and in vitro. Calreticulin is not suﬃcient to account for
all organizer functions but may contribute to the complexity of its activity.
1. Introduction
Neural induction is the process by which signals secreted by the
organizer (Hensen's node in amniotes, a structure at the tip of the
primitive streak) can instruct cells in the epiblast to change their fate
from non-neural (eg. epidermis) to neural plate. In chick, a graft of
Hensen's node to the proximal anterolateral extraembryonic region
(area opaca) can elicit the formation of a complete, patterned nervous
system in less than 24 h (for review see Stern, 2005). Although BMP
inhibition is absolutely required for neural induction to take place (De
Robertis and Kuroda, 2004; Harland, 2000; Hemmati-Brivanlou and
Melton, 1997; Linker and Stern, 2004), it is increasingly clear that
other signals are also required (Stern, 2005). Known additional factors
include FGFs, IGFs andWnt inhibition, but even a combination of all of
these factors is insuﬃcient to mimic the eﬀect of a node graft to the
area opaca in the chick (de Almeida et al., 2008; Linker and Stern,
2004), suggesting that other factors are also involved.
To identify new secreted factors expressed in Hensen's node, we
took advantage of a Signal Sequence Trap, a rapid strategy to isolate
large numbers of cDNAs encoding putative secreted proteins by genetic
selection in yeast. A strain of Saccharomyces cerevisiae with a genomic
deletion at the SUC2 locus (Klein et al., 1996a) is unable to secrete
invertase and is therefore unable to grow on sucrose or raﬃnose as the
sole carbon source. A vector with the SUC2 gene lacking the signal
sequence and the start codon is then used to construct a library of
cDNAs from the tissue of interest. If the cDNA clone provides the
elements required for secretion, the fusion protein is translocated to
the secretion pathway, allowing the transformant to grow on sucrose or
raﬃnose as their only source of carbon (Jacobs et al., 1997).
Here we use this functional genetic screen to seek new secreted
factors from the chick organizer, Hensen's node. Out of 137 putative
secreted factors identiﬁed, 16 have appropriate expression patterns in
the node. These include Calnexin (CANX) and Calreticulin (CALR),
molecules previously well studied in connection with intracellular
Calcium regulation and glycoprotein folding in the endoplasmic
reticulum (Bedard et al., 2005). Misexpression of Calreticulin, but
not Calnexin, at the neural plate border can expand the domain of
expression of neural plate markers, similar to the eﬀect of BMP
antagonists in the same assay. We further show that Calreticulin can
be secreted by cells, that it can inhibit BMP, and that soluble
Calreticulin can bind to BMP4.
2. Materials and methods
2.1. Eggs, embryo manipulations and electroporation
Fertilized hens’ eggs (Brown Bovan Gold; Henry Stewart and
Company) were incubated at 38 °C to the desired stages, following
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the Hamburger and Hamilton system (Hamburger and Hamilton,
1951). Electroporation, whole-mount in situ hybridization and
whole-mount immunostaining were performed using standard meth-
ods as previously described (Sheng et al., 2003; Stern, 1993; Streit and
Stern, 2001; Voiculescu et al., 2008). All DNA solutions for electro-
poration were used at 1.5 μg/µl. FGF8 (50 μg/ml) and Calreticulin
(50 μg/ml) proteins were delivered on heparin beads (Sigma; prepared
as described by Streit et al., 2000).
2.2. Signal Sequence Trap screen and cloning of Calreticulin
A Signal Sequence Trap screen to identify putative secreted factors
was performed in yeast as described by Jacobs et al., 1997) (Fig. 1)
using a cDNA library constructed by Oligo-dT-primed reverse tran-
scription from mRNA puriﬁed from Hensen's nodes of embryos at
stage HH3+-4. All inserts that passed the selection step (see Fig. 1 and
Results) were sequenced and identiﬁed initially by BLAST homology
searches querying public sequence databases.
Full length Calreticulin was obtained from a stage 2–4 cDNA library
as previously described (Streit et al., 2000). The coding regions of chick
Calreticulin (CALR), zebraﬁsh Calreticulin (calr) (Rubinstein et al.,
2000), human Calnexin (CANX) (kind gift from Marek Michalak
(Vassilakos et al., 1998), Xenopus truncated BMP receptor (Suzuki
et al., 1994), cSmad6 (a kind gift from P Szendro and G Eichele) (de
Almeida et al., 2008; Yamada et al., 1999), cChordin (Streit et al.,
1998) and xSmad7 (Casellas and Brivanlou, 1998; de Almeida et al.,
2008) were each cloned into pCAβ-IRES-GFP.
The coding region of Calreticulin was also cloned in the pCDNA
3.1/Myc-His (Invitrogen) expression vector using the NotI and BamHI
cloning sites. Inserts were generated by PCR using the primers
GATCGCGGCCGCATGAGCCGCCTCTGCCTCCCG (adds a NotI restric-
tion site prior to the start codon) and GATCGGATCCTCTTCCTCTCA
GCCTCC (removes the stop codon from Calreticulin and adds a BamHI
restriction site) and pfuTaq polymerase (Promega) (94 °C, 2 min;
42 °C, 2 min; 72 °C, 2 min; 30 cycles). After digestion of both the
PCR fragment and the pCDNA vector with NotI and BamHI, the DNAs
were gel puriﬁed using a gel extraction kit (Promega) and ligated with
T4 ligase (Promega). The resulting plasmid (CALR-Myc) was veriﬁed
by sequencing.
2.3. Cell culture and co-immunoprecipitation
Cell culture and treatments were performed as previously described
(Howell et al., 2002) with a few modiﬁcations: HEK-293T cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) containing
10% fetal bovine serum and transfected using Lipofectamine™ 2000
in combination with Plus Reagent (Invitrogen) according to the
manufacturer's instructions. Cells were seeded at 105 cells per well
in a 6-well plate. The next day, each well was transfected with 1 µg
DNA (either control vector [no insert], dominant-negative BMP
receptor (dnBMPr), CANX or CALR, all in pCAβ-[insert]-IRES-GFP).
To study BMP inhibition, transfected cells were grown for 72 h and
then treated with human BMP4 protein (R &D Systems) at 20 ng/ml
for 1 h prior to preparation of whole cell extracts. Cell lyses and
Western blots were performed as previously described (Howell et al.,
2002).
COS cells were transfected with CALR-Myc, Chordin-Myc (Streit
et al., 1998) or control, empty Vector by a similar method. Pellets of
transfected COS cells for grafting into embryos were generated from
hanging drops as previously described (Streit et al., 1998; Streit and
Stern, 1999).
For co-immunoprecipitations (Co-IP), 500 µl of lysates from trans-
fected cells were clariﬁed by centrifugation for 10 min at 13,200 r.p.m.
at 4 °C and diluted (1:2) in Co-IP wash buﬀer (0.025 M Tris pH7.4,
0.15 M NaCl, 0.001 M EDTA, 1% NP‐40 and 5% glycerol). The sample
was ﬁrst immunoprecipitated with 1–2 µg of the protein-speciﬁc
antibody (either mouse anti-BMP4 IgG, Enzo Life Sciences or rabbit
anti-Calreticulin, Cell Signalling Technology or control mouse or rabbit
Ig [mouse IgG from Santa Cruz, Rb IgG from BD Pharmigen])
overnight at 4 °C on a rocking platform. As additional negative
controls, we used cell lysates of non-transfected HEK-293T cells.
Recombinant BMP4 (Biotechne) and Calreticulin (Abcam) were used
as positive controls, diluted in Co-IP wash buﬀer (up to 1 µg/ml). The
precipitated supernatants (1 ml) were complexed with 20 µl pre-
washed Sepharose L (Santa Cruz) and incubated for 3 h at 4 °C on a
Fig. 1. Identiﬁcation of secreted molecules using the Signal Sequence Trap strategy.
Diagram showing the screen methodology: Hensen's nodes were dissected from Stage 3+-
4 chick embryos; after RNA extraction and reverse transcription the clones were put
through the secretion selection and the resulting sequences further screened by in situ
hybridization.
I. De Almeida et al. Developmental Biology 421 (2017) 161–170
162
rocking platform. After centrifugation and removal of most of the
supernatant, the beads were eluted from the Sepharose by addition of
50 µl of 2×-concentrated sample buﬀer (stock: 100 mM Tris pH6.8, 4%
SDS, 0.2% Bromophenol Blue, 20% glycerol, 20 mM β-mercaptoetha-
nol) for 1 h at 50 °C. The Sepharose was centrifuged for 1 min at
13,000 r.p.m. and the supernatants harvested and stored at −20°C until
ready for Western Blotting. Antibodies against PhosphoSmad1/5/8,
Smad1, Calreticulin, BMP4 (all from Cell Signaling Technology), GFP
(Life Technologies) and Goat anti-rabbit HRP (Santa Cruz) were used
at 1:1000 for Western blots and 1:2000 for immunohistochemistry. A
monoclonal anti-Myc antibody (9E10; Developmental Studies
Hybridoma Bank) was used as a 1:1 dilution of supernatant from the
hybridoma cells.
3. Results
3.1. A Signal Sequence Trap screen to identify putative secreted
molecules in Hensen's node
To identify cDNAs encoding candidate secreted molecules in
Hensen's node at the stage when neural induction takes place, a
cDNA library from stage 3+-4 chick nodes was constructed and
introduced into the pSUC2T7M13ORI vector for yeast transfection as
described by Jacobs et al., 1997) (Fig. 1). After growth in restrictive
medium (to enrich for putative secreted proteins), 442 inserts were
selected. These were sequenced and identiﬁed initially by BLAST. Of
these, 137 clones (31% of the inserts) were selected for further analysis
(Supplementary Table 1); the remainder encoded either 18S RNA
sequences or mitochondrial sequences.
The 137 sequences were further analysed for the presence of a
signal sequence using the SignalP 3.0 algorithm (http://www.cbs.dtu.
dk/services/SignalP/) (Bendtsen et al., 2004; Nielsen et al., 1997a,
1997b). One hundred and three sequences (75%) either encode known
secreted proteins or are predicted to be secreted (Supplementary
Table 1, column headed SP). The proportion of putative secreted
candidates is similar to that obtained by others using comparable
screens (Kaiser et al., 1987).
As a secondary screen for factors that could be involved in neural
induction, we conducted whole-mount in situ hybridization on em-
bryos from before primitive streak formation to about stage 5
(Hamburger and Hamilton, 1951), to determine whether the mRNA
is transcribed in the node at stages 3+-4, when the inducing ability of
the node is strongest (Storey et al., 1992). Sixteen of the transcripts are
enriched in Hensen's node, making them possible candidate molecules
to study in the context of neural induction (Supplementary Fig. 1).
3.2. Calreticulin is expressed in Hensen's node
Of the 16 clones with expression in Hensen's node, two (nhbr307
and nhbw87; Supplementary Fig. 1) encode Calreticulin (CALR) and
Calnexin (CANX) respectively; both are well-studied proteins involved
in protein quality control and Calcium regulation (Chevet et al., 2009;
Fliegel et al., 1989a, 1989b; MacLennan et al., 1974; Michalak et al.,
2009; Ostwald and MacLennan, 1974; Smith et al., 1989; Wada et al.,
1991).
To assess the expression of Calreticulin in more detail at early
stages of chick development, whole mount in situ hybridization was
performed using a full-length CALR clone. Weak expression is ﬁrst
detected throughout the area pellucida epiblast before primitive streak
formation (Supplementary Fig. 1). At stages 3+-4+, expression becomes
concentrated in the anterior primitive streak including Hensen's node
(Fig. 2A-C). At stage 7–8, expression in the node is strongly asym-
metric, concentrated on the right side (Fig. 2D, D′, E). From stage 8,
expression is also seen in the neural plate (Fig. 2E-F) and more weakly
in extraembryonic and lateral mesoderm. From stage 10, expression
appears to become ubiquitous (not shown).
Since Calnexin (which was also identiﬁed in the screen as a possible
secreted molecule in Hensen's node) shares a number of properties
with Calreticulin (Wada et al., 1991), we studied its expression.
Calnexin mRNA levels are weak at early stages of development
although transcripts are slightly concentrated in the node around stage
4 (Supplementary Fig. 2A-C). Thereafter expression becomes more
widespread and becomes concentrated in the neural plate and extra-
embryonic and lateral mesoderm (Supplementary Fig. 2 D-F).
3.3. Calreticulin, but not Calnexin, expands the neural plate
Several molecules with a role in neural induction, such as BMP
antagonists, can expand the neural plate (and laterally displace its
border) into the non-neural territory when misexpressed as a line,
extending outwards from the prospective neural plate (de Almeida
et al., 2008; Delaune et al., 2005; Fisher and Halpern, 1999; Furthauer
et al., 1999; Kuroda et al., 2004; Linker et al., 2009; Linker and Stern,
2004; Papanayotou et al., 2013, 2008; Piccolo et al., 1996; Streit et al.,
1998; Streit and Stern, 1999). To determine whether Calreticulin can
do this, a bicistronic vector encoding Calreticulin and GFP (pCAβ-
CALR-IRES-GFP) was electroporated into the epiblast of stage 3+ chick
embryos in a line extending from within the prospective neural plate to
the area opaca (Fig. 3A). This causes expansion of neural plate markers
like Sox3 (7/15 embryos, 47%; Fig. 3B-C) and Sox2 (9/20, 45%;
Fig. 3D-E) into the non-neural ectoderm. Along with the neural plate,
the neural plate border is also displaced laterally as assessed with msx1
(5/12 cases, 42%; not shown), BMP4 (5/11, 45%; Fig. 3F-G), Pax7 (6/
10, 60%; Fig. 3H-I) and Dlx5 (6/12, 50%; Fig. 3J-K). However, Slug is
downregulated, especially posteriorly (3/7 - 43%; not shown). Notably,
although expansion of the neural plate and lateral shift of its border
was very extensive, the eﬀect never extended to the area opaca. In
control embryos electroporated with the control vector control (pCAβ-
IRES-GFP), no change was seen in expression of Sox3 (0/4), Sox2 (0/
8), BMP4 (0/5), Dlx5 (0/8), Pax7 (0/8), Msx1 (0/7) or Slug (0/4).
We also tested whether Calnexin can expand the neural plate.
Electroporation of pCAβ-CANX-IRES-GFP as a line into the epiblast of
stage 3+ chick embryos (as described above, has no eﬀect on Sox3 (0/
12; not shown) or Sox2 (0/14; Fig. 2G, H), which showed no diﬀerence
to control electroporated embryos (0/8 for Sox3, not shown; 0/8 for
Sox2, Supplementary Fig. 2I, J).
3.4. Calreticulin is insuﬃcient for neural induction in the area opaca
even in combination with FGF and BMP antagonists
When a graft of Hensen's node is placed into the proximal anterior
area opaca, it can induce a full range of neural and border markers
within about 12 h (Dias and Schoenwolf, 1990; Gallera, 1971; Linker
et al., 2009; Linker and Stern, 2004; Pinho et al., 2011; Storey et al.,
1992; Streit et al., 1998, 1997; Streit and Stern, 1999). To test whether
Calreticulin misexpression can induce the competent epiblast of the
area opaca to acquire expression of neural markers, pCAβ-CALR-IRES-
GFP was electroporated into a discrete domain within the inner third of
area opaca at stage 3+, just anterior to the level of Hensen's node
(Fig. 4A). After incubation for 15–20 h, no expression of Sox3 (0/5, not
shown) or Sox2 (0/8; Fig. 4C-D) was observed in the electroporated
region. Control electroporations with pCAβ-IRES-GFP also had no
eﬀect on Sox3 (0/5) or on Sox2 (0/4) expression (not shown).
FGF signalling is required for the initial steps of neural induction as
well as for cells to respond to BMP antagonists (de Almeida et al., 2008;
Delaune et al., 2005; Lamb and Harland, 1995; Launay et al., 1996;
Linker et al., 2009; Linker and Stern, 2004; Papanayotou et al., 2008;
Sasai et al., 1996; Sheng et al., 2003; Streit et al., 2000). The failure of
Calreticulin alone to induce neural markers in the area opaca (see
above) raises the possibility that additional factors are required, such
as FGF and/or BMP antagonism. A graft of a heparin bead soaked in
FGF by itself does not induce either Sox2 or the mesodermal marker
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Brachyury (0/5 of each marker; Fig. 4B-C). A combination of a FGF
bead with electroporation of Calreticulin still fails to induce Sox2 in the
area opaca (0/10; Fig. 4E, F, F‘). Calreticulin was also unable to induce
Sox2 in the presence of both Chordin and FGF8 (0/10; Fig. 4G, H, H‘).
Even a combination of Calreticulin with FGF8 and the BMP antagonists
Chordin (Streit et al., 1998), Smad6 (Imamura et al., 1997) and Smad7
(Casellas and Brivanlou, 1998) is unable to induce Sox2 (0/14; Fig. 4I,
J, J‘) in the area opaca epiblast. These results show that Calreticulin is
unable to induce Sox2 in area opaca epiblast even in combination with
FGF and BMP inhibitors.
3.5. Calreticulin can be secreted by cells
Although Calreticulin is generally viewed as an endoplasmic
reticulum-associated protein (Michalak et al., 2009), its isolation in
the yeast Signal Sequence Trap screen raises the possibility that
Calreticulin might be a secreted protein, as also suggested by previous
authors (Čiplys et al., 2015; Gold et al., 2010). To test whether
expansion of the neural plate can be elicited by soluble, extracellular
Calreticulin, we tested the eﬀect of heparin-beads loaded with recom-
binant Calreticulin protein, grafted close to the prospective neural plate
border. This mimics the eﬀect of misexpression by electroporation: the
domain of Sox2 expression is expanded (4/4; Fig. 5A, A′) and the
border marker msx1 (4/5; Fig. 5C, C′) is shifted laterally. Control
grafted beads did not alter the expression of either Sox2 (0/5; Fig. 5B)
or msx1 (0/4; Fig. 5D).
Next, to test whether Calreticulin can be secreted by cells, we ﬁrst
examined whether a graft of a pellet of COS cells that had been
transfected with CALR could mimic this eﬀect in embryos. In 3/11
embryos, the pellet caused expansion of Sox2 expression in epiblast
adjacent to the grafted cells (Fig. 5E). Control embryos were unaﬀected
(0/6; Fig. 5F). This weak eﬀect could be due to low transfection
eﬃciency of the COS cells and/or to low levels of secretion by these
cells and/or to loss of the expression construct during the culture
period required to make the hanging drop pellets. As a more direct test
for secretion, we plated freshly-transfected COS cells and collected the
supernatant and a lysate of the cells themselves and tested for the
presence of CALR-Myc by Western blotting. As a positive control, we
used Chordin-Myc. Both Chordin-Myc and CALR-Myc could be
detected in the supernatant of transfected cells (Fig. 5G), conﬁrming
that Calreticulin protein can be secreted from cells.
3.6. Calreticulin acts as a BMP antagonist
The above results suggest that Calreticulin can be secreted from
cells, and that misexpression (either by electroporation or applied as an
extracellular signal) can expand the neural plate and displace its border
laterally. These eﬀects are similar to those of BMP antagonists like
Chordin and Noggin (Lamb et al., 1993; Sasai et al., 1994; Streit et al.,
1998; Streit and Stern, 1999), raising the possibility that soluble
Calreticulin could act as a BMP antagonist, perhaps by binding to this
protein and sequestering it away from the receptors. To test this, we
explored whether Calreticulin protein can bind directly to BMP4 by co-
immunoprecipitation (Fig. 6). HEK-293T cells were transfected with
CALR-Myc and BMP4, the medium immunoprecipitated with anti-Myc
and Western blots of protein eluted from the Sepharose beads probed
with anti-BMP4 antibody. A 23 kDa band corresponding to BMP4 is
precipitated (lane 9, arrow). This band is absent from controls:
supernatant from untransfected cells (lanes 1–2) or from transfected
cells (lanes 3–4), Sepharose-bound eluate from untransfected cells
(lanes 6–7), precipitated with control IgG antibody (lanes 1, 3, 6) or
with anti-Myc antibody (lanes 2, 4, 7). It is also absent from the eluate
of transfected cells precipitated with control antibody (lane 8). This
experiment shows that Calreticulin secreted from cells can bind to BMP4.
Fig. 2. Calreticulin is expressed in Hensen's node and neural plate in the chick embryo. Calreticulin transcripts are detected at stage 3-3+(A) with a stronger signal in the anterior part of
the primitive streak. At stages 4-4+, expression becomes concentrated in Hensen's node, with lower levels in the anterior epiblast (B, C). D. From stage 7, expression in Hensen's node is
asymmetric, concentrated on the right side (D, D‘, E). After this stage, expression is concentrated in the neural plate (E, F). HN, Hensen's node.
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To test more directly whether Calreticulin can inhibit BMP activity
in vivo, we repeated the Calreticulin misexpression experiment (a line
extending laterally from the neural plate) and cultured the embryos for
6–8 h. The embryos were then ﬁxed and stained with an antibody
against phospho-Smad1/5/8 (Faure et al., 2002), since BMP signalling
acts by phosphorylating these intracellular proteins (von Bubnoﬀ and
Cho, 2001). Electroporation (green cells in Fig. 7A) caused lateral
expansion of the region devoid of phospho-Smad1/5/8 (Fig. 7B).
Control embryos (electroporated with pCAβ-IRES-GFP) are unaﬀected
(Fig. 7 C-D).
We also tested the ability of Calreticulin to modulate BMP4 activity
in vitro. HEK-293T cells were transfected with various constructs:
empty vector (negative control), dnBMP-receptor (dnBMPr; positive
control), Calnexin and Calreticulin. After 72 h the cells were
stimulated with 20 ng/ml BMP4 protein for 1 h applied to the medium,
harvested and the lysates analysed by Western blotting for
PhosphoSmad1/5/8. Both dnBMPr and Calreticulin repressed the
BMP response, as revealed by the reduced levels of phospho-Smad
after BMP stimulation. In contrast, Calnexin does not inhibit BMP
activity (Fig. 7E, F).
In conclusion, our results show that Calreticulin is expressed in
Hensen's node during the stages of neural induction, that it can be
secreted by cells, and that it can expand the neural plate when
misexpressed close to its border. This latter eﬀect resembles that of
BMP antagonists and we show that Calreticulin can indeed bind to
BMP4 and inhibit BMP activity in vivo and in vitro. Together these
results implicate Calreticulin from the node as an additional BMP
antagonist that may contribute to the neural induction process.
Fig. 3. Calreticulin misexpression extends the neural plate. A. Calreticulin (CALR) was electroporated into the epiblast of stage 3+ chick embryos in a line extending from the node to the
area opaca. B-E. Misexpression causes expansion of the neural plate markers Sox3 (B, C) and Sox2 (D, E). F-K. Along with this, the neural plate border markers BMP4 (F, G), Dlx5 (H, I)
and Pax7 (J, K) are displaced laterally. Note that neither eﬀect extends to the area opaca. In B-K, purple shows the mRNA (in situ hybridization) and brown is anti-GFP to reveal the
electroporated cells. The arrows in B, D, F, H and J point to the lateral expansion of the marker.
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Fig. 4. Calreticulin, either alone or together with FGF and BMP antagonists, cannot induce neural markers in the area opaca. A. Experiments (electroporation and/or a graft of protein-
loaded beads) were performed in the competent extraembryonic epiblast of the area opaca at stage 3+. B. FGF8 alone does not induce the neural marker Sox2 or the mesodermal marker
Brachyury (Bra) in the area opaca. Calreticulin electroporation does not induce Sox2 in the area opaca either by itself (C, D), or when combined with FGF8 (E, F) or with both FGF plus
the BMP antagonists Chd (G, H) and/or Smad6 and Smad7 (I, J). Note that the beads themselves lightly stain during the in situ process (E, G, I); histological sections show the absence
of expression in the epiblast above the beads (F′, H′ and J′).
Fig. 5. Calreticulin is secreted and soluble protein can expand the neural plate. A-D. Soluble Calreticulin can expand the neural plate. Heparin beads soaked in Calreticulin placed at the
boundary of the prospective neural epiblast expand Sox2 expression laterally (A, A′), unlike control beads (B). A similar eﬀect is revealed with the border marker msx1 (C, C′) and this is
also not seen in controls (D). E-G. Calreticulin can be secreted from cells. E-F. Calreticulin-transfected COS cells also cause expansion of the neural plate (E, E′), unlike control COS cells
(F, F′). Pellets of cells and heparin beads are highlighted with a red asterisk. G. COS cells were transfected with Myc-tagged Calreticulin and cultured, and the cell lysate and supernatant
were analysed for Calreticulin in Western blots probed for the Myc tag. A 55 kDa band corresponding to Calreticulin is recovered from both the lysate and supernatant. Myc-tagged
Chordin (100 and 120 kDa bands) was used as a positive control.
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4. Discussion
4.1. The Signal Sequence Trap as a method to identify secreted
molecules
Most eukaryotic secreted proteins (or those that are membrane
bound) contain amino-terminal or internal signal peptides that direct
their sorting to the endoplasmic reticulum (ER). From the ER, proteins
are transported to the extracellular space or the plasma membrane
through the ER-Golgi secretory pathway (Lee et al., 2004; Osborne
et al., 2005). Here we took advantage of a Signal Sequence Trap
method in yeast (Jacobs et al., 1997; Klein et al., 1996b) as a rapid and
relatively simple method for isolating large numbers of cDNAs that
might encode for secreted proteins. It has been used successfully to
identify novel signalling components during vertebrate development
including Derrière (Sun et al., 1999), Frizzled/Sizzled (Bradley et al.,
2000) and CRISP (Smith et al., 2001) proteins.
Kaiser et al. (1987) have shown that about 20% of a large number of
sequences can function to cause secretion in yeast if an initiating
methionine is provided and that many random sequences functionally
replace the secretion signal sequence of yeast invertase. This can lead
to the isolation of many false positives in this screen. In our case, the
majority of the sequences isolated (305/442) encoded either ribosomal
or mitochondrial sequences. Of the remaining 137, 103 (75%) were
either known to be secreted proteins or contained a sequence predicted
to direct secretion. We were surprised that none of the well-studied
secreted proteins expressed in Hensen's node (such as FGF8, Chordin,
ADMP or Sonic hedgehog) were identiﬁed in the screen. It is possible
that some cDNAs did not fuse appropriately in frame with the
invertase. It is also possible that the yeast translational machinery is
unable to generate proteins from some heterologous mRNA sequences.
Another possibility is that some vertebrate signal sequences are not
active in the yeast secretion machinery, which has been shown for some
human proteins (Born et al., 1987).
Using this screening method, we identiﬁed Calreticulin. We show
that it is expressed in Hensen's node at the time of neural induction.
When the chick Calreticulin clone is misexpressed in COS or 293T cells,
the protein can be retrieved from the supernatant and this supernatant
is active as a BMP antagonist. Moreover, when these transfected cells
are transplanted into an embryo, they can expand the neural plate and
inhibit BMP signalling in vivo. This eﬀect can also be demonstrated
using puriﬁed Calreticulin protein applied locally to the embryo. These
results show that Calreticulin can be secreted from cells. Indeed, in
Fig. 6. Calreticulin physically interacts with BMP4. HEK-293T cells were co-transfected
with expression constructs encoding BMP4 and Myc-tagged Calreticulin. After immu-
noprecipitation with anti-Myc antibody (lanes 2, 4, 7, 9) or mouse IgG as control (lanes 1,
3, 6, 8), the supernatant not bound to the Myc-beads (lanes 1–4) and the eluate from the
Myc-beads (lanes 6–9) were analysed by Western blotting, probed with an antibody to
BMP4. A unique band of 23 kDa is precipitated from the co-transfected cells, corre-
sponding to BMP4 (arrow). Lane 10 contains molecular weight markers.
Fig. 7. Calreticulin inhibits the BMP pathway, both in vivo and in vitro. A-D. When
Calreticulin is electroporated as a line extending from the midline to the area opaca and
the embryos cultured for 6–8 h, BMP signalling is inhibited in the electroporated area, as
marked by the loss of anti-phospho-Smad1/5/8 staining in the electroporated region
(corresponding to expansion of the neural plate; arrow in B) (A, B). This is not seen in
control embryos, electroporated with empty vector (C, D). E-F. Calreticulin can lower the
levels of phospho-Smad1/5/8 in vitro. HEK-293T cells transfected with either dnBMPr
(as positive control) or Calreticulin, when stimulated with 20 ng/ml BMP4 for 1 h, show
repression of the BMP signalling, as marked by the lower levels of phosphorylated Smad
1/5/8. Cells transfected with an empty vector or Calnexin do not downregulate the BMP
pathway. The same blot was stripped and re-probed with an antibody against Smad1
(recognising both phosphorylated and non-phosphorylated forms) as a loading control. E
shows the blots, and F shows the ratio between αpSmad1,5,8 and αSmad1 to quantify
relative phosphorylation signal in each sample. This was calculated by dividing the
optical density within the box shown in the αpSmad1,5,8 of the ﬁrst lane over the
corresponding αSmad1 (boxes shown for lane 1). Identical boxes were used for each lane.
The number above each bin is the ratio.
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addition to its better known functions in the ER (Gao et al., 2002;
Ireland et al., 2008; Michalak et al., 2009; Molinari et al., 2004;
Tannous et al., 2015), Calreticulin plays other very important roles
outside the ER, both in physiological and in stress-related conditions
and disease (Gold et al., 2010). For example, secreted and membrane-
associated forms of Calreticulin are important in the host immune
response to cancer with respect to activation of T cells, peptide loading
with tumour antigens and in the phagocytosis of tumour cells by
dendritic cells, which has been used to design chemotherapeutic
approaches (Chaput et al., 2007; Feng et al., 2015; Gardai et al.,
2005; Obeid et al., 2007; Wemeau et al., 2010). Extracellular
Calreticulin also plays an important role in cutaneous wound healing
(Greives et al., 2012; Nanney et al., 2008). These observations add
signiﬁcant strength to our proposal that Calreticulin can be secreted,
and that it may have non-cell-autonomous functions during early
development.
4.2. Functions of Calreticulin in development
Calreticulin appears to fulﬁl many cellular functions, both within
and outside the ER. In the ER lumen it performs two major functions:
chaperoning and regulation of Ca2+ homeostasis (Mery et al., 1996;
Wada et al., 1994). Calreticulin is a highly versatile lectin-like
chaperone (Hebert et al., 1995; Peterson et al., 1995; Spiro et al.,
1996) and it participates in the synthesis of a variety of molecules,
including ion channels, surface receptors, integrin and transporters.
The protein also aﬀects intracellular Ca2+ homeostasis by modulation
of ER Ca2+ storage and transport. Upregulation of Calreticulin leads to
numerous eﬀects in diﬀerent experimental models, including increased
Ca2+ storage capacity of the ER (Mery et al., 1996), modulation of cell
adhesion (Leung-Hagesteijn et al., 1994), modulation of store-operated
Ca2+ inﬂux (Mery et al., 2005, 1996), increased propensity to apoptosis
(Knee et al., 2003), modulation of steroid sensitive gene expression
(Burns et al., 1994) and modulation of the function of another ER
calcium pump, SERCA2 (John et al., 1998). In cell culture, down-
regulation of Calreticulin causes changes in cell adhesion (Coppolino
et al., 1997; Rauch et al., 2000), increased resistance to apoptosis
(Nakamura et al., 2000), abnormal accumulation of misfolded proteins
(Knee et al., 2003), modulation of Ca2+-dependent gene transcription
(Mesaeli et al., 1999) and inhibition of agonist-dependent Ca2+ release
from ER stores (Mesaeli et al., 1999).
However almost nothing is known about the functions of
Calreticulin during development. Homozygous Calreticulin mutant
mice die at E14.5 (Mesaeli et al., 1999) with impaired cardiac
development and problems in Ca2+-dependent transcriptional path-
ways (Guo et al., 2002; Mesaeli et al., 2001, 1999), and also display
brain and body wall defects (Rauch et al., 2000). A zebraﬁsh
Calreticulin homologue was ﬁrst isolated in a screen for genes whose
expression is dependent on Cyclops signalling (a Nodal homologue); it
is expressed in the embryonic shield (the zebraﬁsh organizer) but no
function was assigned to it (Rubinstein et al., 2000).
Our results reveal that Calreticulin is expressed in Hensen's node,
that it can be secreted from cells and that soluble Calreticulin can act as
a BMP antagonist both in vivo and in vitro. Since Calreticulin null
mutant mice do not fail to form a nervous system, it is unlikely that
Calreticulin is the most important single BMP inhibitor expressed in
the organizer at the time of neural induction. However at this stage the
node co-expresses Chordin (Streit et al., 1998), making it likely that the
roles of these two inhibitors partly overlap or are synergistic. Since
Chordin mutants have severe defects but do not fail to induce a nervous
system (Bachiller et al., 2000), it may be interesting to explore the
phenotype of Chordin-Calreticulin double-mutants. Nevertheless, our
results point to a previously undescribed function of Calreticulin, which
may be more widespread than just during development.
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